Elizabeth Mily, the lead acquisition and deal negotiator at Bristol Myers Squibb, is leaving the Big Pharma, a spokesperson confirmed to Endpoints News on Friday morning. Since joining Bristol Myers in the spring of 2020 […]
The finish line is in sight for the Texas Children’s Hospital campus in North Austin — its first outside of the Houston area — but there’s still plenty of room to grow. Click here to […]
A Durham startup is working with Boehringer Ingelheim on a drug discovery effort targeting unmet medical needs. Click here to view original post Click here to view North Carolina Biotech Networks Trending News
Quietly, Nooshee, a Raleigh femtech startup looking to develop a smart breast pump for new moms, is raising millions as it works in stealth to develop its first product. Click here to view original post […]
There may be a solid chunk of executives in the Endpoints 100 who feel that better times are ahead for the biotech industry in 2024, but they’re still outnumbered by doubters and the undecided. This […]
Kamau Therapeutics has emerged from stealth mode after inking a deal with Graphite Bio for its genome editing assets. Kamau’s debut comes less than a month after Graphite entered a reverse merger deal with Lenz […]
Alexandra Glucksmann Alexandra Glucksmann is always looking for “the next frontier” in medicine. After spending most of her career in genetic diseases, rare diseases and oncology, her next pursuit is in mental health. The longtime […]
The head of the company producing the show says his team worked for weeks to produce the program that will mark the Allen Institute’s 20 years of operation. Click here to view original post Click […]
Renderings Credit: Kisco Senior Living CARLSBAD, Calif. and BROOKLINE, Mass., Dec. 7, 2023 /PRNewswire/ — Kisco Senior Living proudly introduces its premier lifestyle brand, Kisco Signature, to the Boston area with The Newbury of Brookline. […]
SAN DIEGO–(BUSINESS WIRE)–MBrace Therapeutics, Inc. (“MBrace”), a clinical-stage biopharmaceutical company devoted to improving the lives of cancer patients through the development of antibody-drug conjugates (ADCs) against novel oncology targets, today announced new preclinical data supporting […]
© 2023 Biotech Networks, LLC
